Data updated: Mar 29, 2026

NIVAGEN PHARMS INC

Oncology

Generics

NIVAGEN PHARMS INC is a generic drug manufacturer focused on Oncology.

2020

Since

5

Drugs

-

Trials

28

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

TEMOZOLOMIDE 2026-01-22

TEMOZOLOMIDE 2026-01-22

DECITABINE 2025-12-19

TEMOZOLOMIDE 2025-07-01

DECITABINE 2025-07-01

DECITABINE 2025-06-20

DECITABINE 2025-06-20

DECITABINE 2025-06-20

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 100%

1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma

Novartis big-pharma

Merck big-pharma

Baxter specialty

AbbVie big-pharma